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Background: Emergency physicians see many people who present to the emergency department stating that
they are immunized against tetanus, when in fact, they are not. The patient history is not dependable for
determining true tetanus status and simple patient surveys do not provide actual prevalence. The objective of
this study was to determine the prevalence of tetanus status by antibody titer seropositivity and quantify such
status among patients reporting tetanus protection.
Methods: This study is a single center prospective convenience sample of patients presenting to the emergency
department 12 years of age or older. Patients deemed study candidates and willing to be in the study filled out
an eight-question questionnaire that included the question ‘is your tetanus shot up to date’. A blood sample
was then drawn for tetanus antibody titer and quantified according to a pre-determined cutoff for protection.
Results: A total of 163 patients were enrolled. Of patients responding yes to the query ‘is your tetanus shot up
to date’ 12.8% (N 5) of them were not seropositive. Of the 26 people who were seronegative in the study all
had been to a doctor in the past year and 88.5% (N 23) had been to their family physician.
Conclusion: The study suggests that it may be difficult to trust the tetanus immunization history given by
patients presenting to the emergency room. The study also observed that a large percentage of patients who
were serenegative were seen by a primary care physician and not had a necessary tetanus immunization.
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T
etanus is a disease in which the spores of
Clostridium tetani are introduced into the human
body most often through a wound. The spores
then germinate under anaerobic conditions and produce
the two toxins tetanosposmin and tetanolysin. Tetanos-
pasmin travels from the inoculation site via retrograde
axonal transmission and binds irreversibly at the spinal
cord and brain. The toxin blocks neuronal release of
neurotransmitters. The neurons that release inhibitory
neurotransmitters are particularly susceptible to tetanos-
pasmin. The result is painful and a potentially lethal
generalized muscle spasm (1).
As physicians, tetanus is a disease that is thought about
often, vaccinated for, and in the United States encoun-
tered very rarely today. It is reported less than 50 times a
year in the US (average annual incidence of 0.16 cases/
million population) (2). Worldwide, the annual incidence
of tetanus is 0.5 1 million cases per year (2). Incidence
and mortality has decreased steadily and the difference
has been attributed to universal vaccination with the
tetanus toxoid that began in the 1940’s (diphtheria and
tetanus toxoids and whole-cell pertussis vaccine-pediatric
[DTP] vaccine) (2).
In US emergency rooms access to patient vaccination
records is a rare luxury. Other means of obtaining
vaccination status have been reported. A study in Iran
evaluated the usefulness of a tetanus quick stick, essen-
tially a rapid finger prick test used in the emergency
department for determining immunization status (3).
Results are promising, however, the test is not widely
available and the interview of the patient still remains
the primary means of determining if a patient is up to
date with their tetanus vaccination. According to the
CDC, the case-fatality ratio for tetanus was 18% among
those with a known outcome (2). However, no deaths
have occurred among those who were up-to-date with
tetanus toxoid vaccination. In addition, 73% of those
with known injury information reported an acute injury
yet only 37% sought medical care. Patient education
is important and knowing that the tetanus vaccine does
not result in lifetime immunity makes the date of the
immunization extremely important.
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prevalence of tetanus antibody seropositivity among
emergency patients perceiving tetanus protection. A sig-
nificant number of people who present to the emergency
department state that they are up to date on their tetanus
vaccination (4). Actual immunity against tetanus is likely
much lower. A study from Australia found that at least
half of those over the age of 50 have a concentration of
tetanus antitoxin (B 0.15 IU/mL) that are thought to be
too low to be protected (5). We suspect that a significant
number of them have visited their primary physician
within the previous year.
Methods
Study design
This cross-sectional study design utilized a single center
prospective convenience sample of patients (12 years of
age and older) presenting to the emergency department.
The study received approval by the hospital IRB. Data
collection occurred from April 2006 to November 2007.
This is a community teaching hospital with 410 beds
and 85,000 visits per year including more than 25,000
trauma cases per year. Power analysis determined that
a sample of 200, allowing for a 15% drop out rate, would
be needed to estimate prevalence and conduct subgroup
analysis for our descriptive intent. Patients visiting the
emergency department at the start of the study were
categorized by age groups (0 17: 27%, 18 35: 33%, 36 64:
30%,  64: 10%) to track age distribution during study
implementation.
Subjects
The inclusion criteria were patients 12 years of age and
older who present to the emergency department on a shift
covered by the study investigators. We included the 12 17
year ages in order to expand the target population of
wound injuries presenting to the emergency department.
A convenience sample of patients selected consecutively
on shifts covered by a study physician was conducted for
survey enrollment. Patients were excluded if they had
dementia or an altered mental status that prohibited a
reliable history. Patients were also excluded if they had
been involved in a medical or traumatic resuscitation due
to potential issues with the ability to understand consent.
Patients deemed candidates for the study (or their
parents) were approached by study investigator physicians
about taking part in the study. Informed consent was
obtained and they were given an eight item questionnaire
to fill out without the help of medical staff or people
accompanying them (Appendix 1). The questionnaire
had not been previously validated. The nursing staff
then collected a one-milliliter blood sample by peripheral
venipuncture for a tetanus antibody titer. The question-
naire was collected during the same shift. The blood
sample was sent to ARUP laboratories to be analyzed.
ARUP Laboratories is a national clinical and pathology
reference laboratory (University of Utah, Salt Lake City,
UT). ARUP labs use Muiti-analyte Fluorescent Detection
for the tetanus antibody titer.
Procedures
The Laboratory uses Multi-analyte Fluorescent Detec-
tion for the tetanus antibody titer. A concentration of
greater than 0.01 IU/ml is considered a protective
concentration of tetanus antibody. The sensitivity of
Multi-analyte Fluorescent Detection in the ARUP lab
is 93.2% and the specificity is 95%. The lab and its
performance with Multi-analyte Fluorescent Detection of
the tetanus antibody were validated against the standard
set by the World Health Organization (7). The serology
department at the study hospital collected the results
from ARUP labs. These results were then paired with
the patient questionnaires for final analysis.
Outcomes
The primary outcome was the prevalence of seropositivity
among patients presenting to the emergency department
who perceive being protected against tetanus. Secondary
outcomes were the prevalence of people who are serone-
gative who have visited their primary physician within
10 years and mean duration of time since visiting a
primary care physician in patients who are seronegative.
Frequency distributions were calculated for each question
and comparisons of subgroups were analyzed by the
Chi-square statistic (p-value 0.05).
Results
The total number of people in the final survey was
163. Middle age was the predominant age category
(Fig. 1). The majority of respondents were female
(n 98 or 60%). Distribution of subjects by age cate-
gories is in Table 1. The largest category was the 80 years
and older with 30 subjects (18.4%) participating.
Laboratory tests demonstrated a seronegative (titer
0 0.09 IU) prevalence of 16% (n 26) and seropositive
(title 0.1 IU) prevalence of 84% (n 137). The youngest
age groups tended to be fully protected while the
older age groups tended to have significant proportions
unprotected (see Table 1). There was no difference
in mean titer levels between genders (males 1.86,
females 1.83; p 0.56).
There was no correlation between seropositivity and
previous visit with a physician (r 0.11, p 0.16). Of
the patients who were seronegative, and therefore requir-
ing a tetanus booster, all (100%, n 26) reported having
visited a physician in the past year.
Of the patients who assumed their tetanus protection
was current (receivedwithin the previous 10 years), 12.8%
(n 5) were actually seronegative (Table 2). Of the 31
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titers showing they were protected. The sensitivity of
self-reported protection was 87% and specificity was
35%. A majority overall (78.4%, n 122) reported
that tetanus shots should be updated every 5 10 years
(Table 2) and a majority of those seropositive reported a
preference for tetanus updates every 5 10 years (84.6%,
n 33). The likelihood of reporting that tetanus updates
should be every 5 10 years did not differ bygender (males
12.3%, females 8.2%; OR 1.6, p 0.34). There were no
differences in belief about keeping ones tetanus protec-
tion current based on titer status. Those who reported
being protected were no more likely to assert that
tetanus status should be kept current than those who
reported being unprotected (OR ,p 0.). Overall recall
of last tetanus shot was split among the time categories
(Table 3) with 13.5% reporting that they did not recall
when they had it. A slight majority (50.9%) reported
that it was at the family doctor’s office where they
received it (Table 3). Among those who were seropositive
(n 127), 15.7% (n 20) erroneously thought that they
lacked protection. A large majority of the positive
group were uncertain of their protection status (n 83,
65.4%) Those who were confident of their lack of
protection were indeed more likely to be seronegative
(35.5%) compared to those who were unsure of their
protection (10.8%) [Relative Risk Difference 69.5%,
p 0.0018].
A majority (93.3%) overall reported that they had
seen their doctor within the last year yet the majority
also reported that their physician did not inquire
about tetanus status (Table 4). There was no correlation
between the timing of vaccination reported and when
patients reported their last visit with a physician was
(r 0.097, p 0.25). Among patients who were serone-
gative (n 26) all reported visiting their physician within
5.5
16
31.3 28.8
18.4
0
10
20
30
40
50
60
70
80
90
100
12 -- 19 20 -- 39 40 -- 59 60 -- 79 80+
n=51 n=47 n=26 n=9 n=30
P
e
r
c
e
n
t
Fig. 1. Respondent frequency by age category.
Table 1. Protection by age and gender distribution
Category Number (%) Titer status [# (%)]
Male 65 (39.9) Unprotected 9 (13.8)
Protected 56 (86.2)
Female 98 (60.1) Unprotected 17 (17.3)
Protected 81 (82.7)
12 19 9 (5.5) Unprotected 0 (0)
Protected 9 (100)
20 29 12 (7.4) Unprotected 0 (0)
Protected 12 (100)
30 39 14 (8.6) Unprotected 1 (7.1)
Protected 13 (92.9)
40 49 28 (17.2) Unprotected 2 (7.1)
Protected 26 (92.9)
50 59 23 (14.1) Unprotected 0 (0)
Protected 23 (100)
60 69 19 (11.7) Unprotected 5 (26.3)
Protected 14 (73.7)
70 79 28 (17.2) Unprotected 6 (21.4)
Protected 22 (78.6)
80 or greater 30 (18.4) Unprotected 12 (40.0)
Protected 18 (60.0)
Total 163 (100) Unprotected 26 (16.0)
Protected 137 (84.0)
Table 2. Perceived protection
Response Number (%) Total 163
I am protected 39 (23.9)
I am not protected 31 (19.0)
I don’t know 93 (57.1)
Tetanus shots should be updated how often?
1 5 years 17 (10.4)
5 10 years 122 (74.8)
  10 years 1 (0.6)
Don’t know 23 (14.1)
Total 163
Perceived tetanus protection in ED patients
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doctor as a primary care physician.
Discussion
Since the 1940’s annual reports of tetanus have been
reduced by 96% in the United States due to use of the
tetanus vaccine and the tetanus toxoid (2). More recently,
Gergen et al. showed in a serologic survey that 69.7% of
Americans six years of age and older are seropositive (5).
However, depending on actual age, this percentage can
vary greatly. For instance, among those greater than 70
years of age only 27.8% of Americans have seroprotective
tetanus antibody levels (2). Talan et al. demonstrated
that even in emergency departments, in which there is
an awareness of current standards established by the
CDC for tetanus vaccination in patients with wounds,
they fall short of proper tetanus prophylaxis (6). This was
particularly the case when involving patients who qualify
for tetanus immunoglobulin.
In theUnited States, theelderly population, immigrants
and intravenous drug abusers are all patient populations
that have been found to have negative seropostivity for
tetanus (2, 6, 7). With the ever-increasing number of
geriatric patients presenting to the emergency department
it seems of obvious importance to improve awareness of
this disease and be more aggressive with vaccination.
Awareness of tetanus status was an issue among the
current study population. The findings suggest that at
least 12% of seronegative individuals are under the false
impression that they are protected. If injured, this
proportion of people would not get immunized by
standard practices. This brings forth the point of our
study, that without immunization records it is difficult to
trust the history a patient provides in regards to tetanus
immunization status. The decision for emergency physi-
cians is whether to vaccinate all individuals with wounds
regardless of the history provided. The tetanus vaccine is
fairly inexpensive (approximately $15 to hospitals) and is
easily given. Even so, this does not eliminate the need for
a thorough patient history as some individuals will also
require the tetanus immunoglobulin.
The study findings also highlight a total seropositive
prevalence of 84%. This should be noted because it is
slightly higher than previous larger studies such as
Gergen (5), which demonstrated an overall seropositivity
closer to 70%. The difference in prevalence may be due to
differences in immigrant populations, differences in
primary care practices, or possible differences in labora-
tory equipment. The current practice guidelines as
mentioned in American Academy of Family Physicians
recommends a tetanus booster every 10 years, a primary
series if not done previously and a ‘do not administer’ if
life expectancy is less than two years (8). Also of note is
that the Gergen study used 0.15 IU/ml as a positive result
for seropositivity as compared to the use of 0.1 IU/ml by
ARUP laboratories and this study (5).
Broad generalization from this study is limited by its
use of a convenience sample of patients and having been
conducted at a single community hospital center. The
type of patients presenting during enrollment periods of
study physician coverage could have influenced the out-
come. However, its findings reflect this community and
are generalizable to the typical Midwestern, middle class
community. If replicated, the most important modifica-
tion would be to conduct a multi center study that
includes urban hospitals with random selection of
patients across all shifts. This would provide a broader
picture of tetanus protection awareness.
Conclusion
Tetanus immunization history in patients presenting
to the emergency department is not accurate. Tetanus
Table 4. Perceptions about physician encounters
Response Number (%) Total 163
When was the last time you went to a doctor?
1 year or less 152 (93.3)
Between 1 and 5 years 5 (3.1)
Between 5 and 10 years 6 (3.7)
What type of doctor did you last visit for care?
ER doctor 14 (8.6)
Urgent care doctor 1 (0.6)
Family doctor 127 (77.9)
Other 16 (9.8)
Blank 5 (3.1)
During that last visit to the doctor, did they ask you if you were up
to date on your tetanus shot?
Yes 16 (9.8)
No 121 (74.2)
Not sure 26 (16.9)
Table 3. Tetanus vaccine history
Response Number (%) Total 163
When did you last receive your tetanus shot?
B 5 years 40 (24.5)
5 10 years 45 (27.6)
  10 years 56 (34.4)
Don’t know 22 (13.5)
Where did you receive your last tetanus shot?
Emergency room 30 (18.4)
Urgent care/clinic 14 (8.6)
Family doctor 83 (50.9)
Other 10 (11.0)
Don’t know 26 (4.9)
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to be modified to protect the public from unavoidable
error in the current tetanus immunization decision tree.
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Appendix 1
1) Is your tetanus shot up to date?
Yes No I don’t know
2) When was your last tetanus shot?
Date____
or
Less than 5 years ago
5 10 years ago
More than 10 years ago
3) How often do you think it is recommended a tetanus
shot should be updated?
Every ______ years
4) Where did you last get your tetanus shot?
Emergency Room
Walk in Clinic (Urgent Care)
Family Doctor (Primary Care Doctor)
Other______________
5) When was the last time you went to a doctor?
_______Years________Months
6) Before today’s Emergency Room visit, what type of
doctor have you last visited for care?
Emergency Room Doctor
Walk in Clinic Doctor (Urgent Care)
Family Doctor (Primary Care)
Other__________
7) When was your last visit to your family doctor?
________Years________Months
or
I don’t have a family doctor
8) During your last visit to a doctor did they ask you if
you were up to date on your tetanus shot?
Yes No Not Sure
Perceived tetanus protection in ED patients
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